The temporal distribution of AE reports showed an increasing trend, peaking in 2014 (10.85%), 2016 (8.59%), 2015 (8.32%), 2017 (7.32%), 2024 (7.05%), and 2023 (6.69%).
← all excerpts
Adverse effects of iodixanol: A retrospective safety study utilizing FAERS database signal analysis.
1
—
—